Persistence Market Research Company
Customize Now Get FREE Sample

Global Drug Induced Cardiotoxicity Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Drug Induced Cardiotoxicity Market by Drug Class{Tyrosine Kinase Inhibitors (TKIs), Antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)}, Type (Chemotherapy-Induced Cardiotoxicity, Antipsychotic Drug-Induced Cardiotoxicity), Detection (Biomarkers, Imaging Techniques), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), and Regional Analysis from 2026 to 2033

ID: PMRREP32329| 200 Pages | 5 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Drug Induced Cardiotoxicity Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
    3. Global Drug Induced Cardiotoxicity Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
        1. Tyrosine Kinase Inhibitors (TKIs)
        2. Antibiotics
        3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      4. Market Attractiveness Analysis: Drug Class
    4. Global Drug Induced Cardiotoxicity Market Outlook: Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Type, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
        1. Chemotherapy-Induced Cardiotoxicity
        2. Antipsychotic Drug-Induced Cardiotoxicity
      4. Market Attractiveness Analysis: Type
    5. Global Drug Induced Cardiotoxicity Market Outlook: Detection
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Detection, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
        1. Biomarkers
        2. Imaging Techniques
      4. Market Attractiveness Analysis: Detection
    6. Global Drug Induced Cardiotoxicity Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers
        4. Others
      4. Market Attractiveness Analysis: End User
  5. Global Drug Induced Cardiotoxicity Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  7. Europe Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  8. Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  10. Latin America Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Drug Induced Cardiotoxicity Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Detection
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Tyrosine Kinase Inhibitors (TKIs)
      2. Antibiotics
      3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Chemotherapy-Induced Cardiotoxicity
      2. Antipsychotic Drug-Induced Cardiotoxicity
    6. Market Size (US$ Bn) Analysis and Forecast, By Detection, 2026 – 2033
      1. Biomarkers
      2. Imaging Techniques
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Novartis AG
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Pfizer Inc
      3. Siemens Healthineers
      4. GE Healthcare
      5. Amgen Inc
      6. Bristol Myers Squibb
      7. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate